St. Jude Children's Research Hospital, founded in 1962, is a pediatric treatment and research facility focused on children's catastrophic diseases, particularly leukemia and other cancers. The hospital costs about US$2.8 million a day to run, but patients are not charged for their care.

During the past decade, St Jude s Childrens Research Hospital Dept of Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "St Jude s Childrens Research Hospital Dept of Oncology" are "ALK-activated Tumors" (1 trials), "Malignant Rhabdoid Tumors (MRT)" (1 trials) and "Neuroblastoma" (1 trials). Many other conditions were trialed in "St Jude s Childrens Research Hospital Dept of Oncology" in a lesser frequency.

Most popular intervention types in "St Jude s Childrens Research Hospital Dept of Oncology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ceritinib" (1 trials) and "LEE011" (1 trials). Other intervention names were less common.

The vast majority of trials in "St Jude s Childrens Research Hospital Dept of Oncology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "St Jude s Childrens Research Hospital Dept of Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in St Jude s Childrens Research Hospital Dept of Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St Jude s Childrens Research Hospital Dept of Oncology, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".